Time & Date: 3 September, 11:15 – 12:15 CEST
Chairpersons: B. Leroy USA & I. Audo FRANCE
Speakers:
Presentations:
Speakers & Presentations:
B. Leroy USA
11:15 Introduction
Speakers & Presentations:
A. Auricchio ITALY
11:18 Expanding AAV Transfer Capacity in the Retina
D. Fischer GERMANY
11:24 Luxturna in Clinical Practice: The PERCEIVE Study
I. Audo FRANCE
11:30 Optogenetics: The Generic Future?
P. Sieving USA
11:36 Intravitreal AAV-based Gene Therapies: XLRS
B. Leroy USA
11:42 RNA Interference Therapy for CEP290-IRD
I. Audo FRANCE
11:48 RNA Interference Therapy for USH2A-IRD
M. Pennesi USA
11:54 CRISPR/Cas9 for Inherited Retinal Disease
All Faculty
12:00 Discussion
Programme details may be subject to change. Please refer to the interactive programme for the most up to date details.